These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1290617)

  • 1. Angiotensin II receptors and functional correlates.
    Timmermans PB; Benfield P; Chiu AT; Herblin WF; Wong PC; Smith RD
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):221S-235S. PubMed ID: 1290617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB; Smith RD
    Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
    Hogarty DC; Speakman EA; Puig V; Phillips MI
    Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor subtypes.
    Timmermans PB; Chiu AT; Herblin WF; Wong PC; Smith RD
    Am J Hypertens; 1992 Jun; 5(6 Pt 1):406-10. PubMed ID: 1524767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
    Toney GM; Porter JP
    Brain Res Dev Brain Res; 1993 Feb; 71(2):193-9. PubMed ID: 8491041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human angiotensin receptor subtypes.
    Smith RD; Timmermans PB
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):112-22. PubMed ID: 7850406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New perspectives in angiotensin system control.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Smith RD
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S19-31. PubMed ID: 8230085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
    Eberhardt RT; Kevak RM; Kang PM; Frishman WH
    J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the chemical development of angiotensin II receptor antagonists.
    Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor subtypes: selective antagonists and functional correlates.
    Timmermans PB; Smith RD
    Eur Heart J; 1994 Dec; 15 Suppl D():79-87. PubMed ID: 7713119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats.
    Gigante B; Piras O; De Paolis P; Porcellini A; Natale A; Volpe M
    J Hypertens; 1998 Dec; 16(12 Pt 2):2039-43. PubMed ID: 9886894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin receptors and their therapeutic implications.
    Griendling KK; Lassègue B; Alexander RW
    Annu Rev Pharmacol Toxicol; 1996; 36():281-306. PubMed ID: 8725391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor pharmacology and AT1-receptor blockers.
    Chung O; Csikós T; Unger T
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S11-20; discussion S33-4. PubMed ID: 10076916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin II receptor antagonists].
    Bornkessel B
    Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin receptors: physiology and pharmacology.
    Guthrie GP
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats.
    Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG
    Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC; Timmermans PB
    Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.